Comparable short-term prognosis in diabetic and non-diabetic patients with acute coronary syndrome after cardiac rehabilitation

European Journal of Preventive Cardiology

Volumn 19, Issue 1, 2012, Pages 15-22

  Reibis, R ^a   Treszl, A ^b   Bestehorn, K ^c   Karoff, M ^d   Schwaab, B ^e   Wirth, A ^f   Von Horlacher, J ^a   Jannowitz, C ^c   Pittrow, D ^g   Wegscheider, K ^b   Voller H ^a  

^a Klinik Am See   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MSD Sharp and Dohme GmbH   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e Department of Cardiovascular Rehabilitation   (Germany)

^f Klinik Teutoburger Wald   (Germany)

^g Institute of Medical Informatics and Biometry   (Germany)

Author keywords

Acute coronary syndrome; cardiac rehabilitation; diabetes mellitus; end organ damage; impaired glucose tolerance; prognosis; target value attainment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; HEMOGLOBIN A1C;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR MORTALITY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE REGISTRY; GERMANY; GLUCOSE ASSAY; GLUCOSE METABOLISM; HOSPITAL DISCHARGE; HOSPITAL READMISSION; LIPOPROTEIN BLOOD LEVEL; MORTALITY; OBSERVATIONAL STUDY; STROKE; SYSTOLIC BLOOD PRESSURE;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GERMANY; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT DISCHARGE; PATIENT READMISSION; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856912848     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/1741826710393993     Document Type: Article

References (29)

1. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE., et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007; 356: 2388–2398.
2. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J., et al. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 2004; 164: 1438–1443.
3. Schramm TK, Gislason GH, Køber L, Rasmussen S, Rasmussen JN, Abildstrøm SZ., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008; 117: 1945–1954.
4. Anselmino M, Bartnik M, Malmberg K, Rydén L. Management of coronary artery disease in patients with and without diabetes mellitus. Acute management reasonable but secondary prevention unacceptably poor: a report from the Euro Heart Survey on Diabetes and the heart. Eur J Cardiovasc Prev Rehab 2007; 14: 28–36.
5. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003; 26: S5–S20.
6. Karoff M, Held K, Bjarnason-Wehrens B. Cardiac rehabilitation in Germany. Eur J Cardiovasc Prev Rehab 2007; 14: 18–27.
7. Bjarnason-Wehrens B, McGee H, Zwisler AD, Piepoli MF, Benzer W, Schmid JP., et al. Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey. Eur J Cardiovasc Prev Rehabil 2010; 17: 410–418.
8. Molenberghs G, Kenward MG Missing data in clinical studies. 2007 Chichester: John Wiley 105–118.
9. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–2559.
10. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Rydén L., et al. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004; 25: 1990–1997.
11. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007; 28: 88–136.
12. Prospective Diabetes Study Group UK. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–713.
13. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–1762.
14. Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL., et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA 2010; 304: 61–68.
15. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008; 358: 580–591.
16. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575–1585.
17. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227–239.
18. American Diabetes Association. Standards of medical care in diabetes – 2008. Diabetes Care 2008; 31: S12–S54.
19. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D., et al. Implications of diabetes in patients with acute coronary syndromes. Arch Intern Med 2004; 164: 1457–1463.
20. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L., et al. Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838–844.
21. The ADVANCE Collaborative Group. Intensive blood–glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–2572.
22. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. for the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–139.
23. Holman RR, Paul SK, Bethel A, Matthews DR, Neil AW. 10-year follow-up of intensive glycemic control in type 2 diabetes. N Engl J Med 2008; 359: 1577–1589.
24. Preis SR, Hwang SJ, Coady S, Pencina MJ, D’Agostino RB Sr, Savage PJ., et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009; 119: 1728–1735.
25. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP., et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765–775.
26. de la Hera JM, Delgado E, Hernández E, García-Ruiz JM, Vegas JM, Avanzas P., et al. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention. Eur Heart J 2009; 30: 2614–2621.
27. Diehm C, Darius H, Burghaus I, Mahn M, Pittrow D. Ankle brachial index vs metabolic syndrome for risk prediction. Lancet 2008; 372: 1221–1221.
28. Morillas P, Cordero A, Bertomeu V, Gonzalez-Juanatey JR, Quiles J., et al. Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens 2009; 27: 341–347.
29. The Ankle Brachial Index Collaboration. Ankle Brachial Index combined with Framingham Risk Score to predict cardiovascular events and mortality. JAMA 2008; 300: 197–208.